Ischemia-reperfusion Injury of the Lung: Role of Surfactant

  • N.P. Van der Kaaij
  • A.J.J.C. Bogers
  • B. Lachmann
Conference paper
Part of the EN]Yearbook of Intensive Care and Emergency Medicine book series (volume 2005)


Lung Transplantation Bronchiolitis Obliterans Syndrome Pulmonary Surfactant Lung Transplant Recipient Surfactant Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ (2000) The registry of the international society for heart and lung transplantation: Seventeenth official report-2000. J Heart Lung Transplant 19:909–931CrossRefPubMedGoogle Scholar
  2. 2.
    Veldhuizen RA, Lee J, Sandler D, et al (1993) Alterations in pulmonary surfactant composition and activity after experimental lung transplantation. Am Rev Respir Dis 148:208–215PubMedGoogle Scholar
  3. 3.
    Erasmus ME, Petersen AH, Oetomo SB, Prop J (1994) The function of surfactant is impaired during the reimplantation response in rat lung transplants. J Heart Lung Transplant 13:791–802PubMedGoogle Scholar
  4. 4.
    Erasmus ME, Petersen AH, Hofstede G, Haagsman HP, Bambang Oetomo S, Prop J (1996) Surfactant treatment before reperfusion improves the immediate function of lung transplants in rats. Am J Respir Crit Care Med 153:665–670PubMedGoogle Scholar
  5. 5.
    Novick RJ, Gilpin AA, Gehman KE, et al (1997) Mitigation of injury in canine lung grafts by exogenous surfactant therapy. J Thorac Cardiovasc Surg 113:342–353PubMedGoogle Scholar
  6. 6.
    Novick RJ, Veldhuizen RA, Possmayer F, Lee J, Sandler D, Lewis JF (1994) Exogenous surfactant therapy in thirty-eight hour lung graft preservation for transplantation. J Thorac Cardiovasc Surg 108:259–268PubMedGoogle Scholar
  7. 7.
    Khan SU, Salloum J, O'Donovan PB, et al (1999) Acute pulmonary edema after lung transplantation: The pulmonary reimplantation response. Chest 116:187–194CrossRefPubMedGoogle Scholar
  8. 8.
    King RC, Binns OA, Rodriguez F, et al (2000) Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 69:1681–1685CrossRefPubMedGoogle Scholar
  9. 9.
    Lee KH, Martich GD, Boujoukos AJ, Keenan RJ, Griffith BP (1996) Predicting icu length of stay following single lung transplantation. Chest 110:1014–1017PubMedGoogle Scholar
  10. 10.
    de Perrot M, Liu M, Waddell TK, Keshavjee S (2003) Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 167:490–511CrossRefPubMedGoogle Scholar
  11. 11.
    Lachmann B (1987) The role of pulmonary surfactant in the pathogenesis and therapy of ARDS. In: Vincent JL (ed) Update in Intensive Care and Emergency Medicine. Springer, Heidelberg, pp 123–124Google Scholar
  12. 12.
    Ingbar DH (2000) Mechanisms of repair and remodeling following acute lung injury. Clin Chest Med 21:589–616CrossRefPubMedGoogle Scholar
  13. 13.
    Boehler A, Kesten S, Weder W, Speich R (1998) Bronchiolitis obliterans after lung transplantation: A review. Chest 114:1411–1426PubMedGoogle Scholar
  14. 14.
    Fiser SM, Tribble CG, Long SM, et al (2002) Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 73:1041–1047CrossRefPubMedGoogle Scholar
  15. 15.
    Tullius SG, Tilney NL (1995) Both alloantigen-dependent and-independent factors influence chronic allograft rejection. Transplantation 59:313–318PubMedGoogle Scholar
  16. 16.
    Andrade RS, Solien EE, Wangensteen OD, Tsai MY, Kshettry VR, Bolman RM, 3rd (1995) Surfactant dysfunction in lung preservation. Transplantation 60:536–541PubMedGoogle Scholar
  17. 17.
    Klepetko W, Lohninger A, Wisser W, et al (1990) Pulmonary surfactant in bronchoalveolar lavage after canine lung transplantation: Effect of l-carnitine application. J Thorac Cardiovasc Surg 99:1048–1058PubMedGoogle Scholar
  18. 18.
    Erasmus ME, Veldhuizen RA, Novick RJ, Lewis JF, Prop J (1996) The effect of lung preservation on alveolar surfactant. Transplantation 62:143–144PubMedGoogle Scholar
  19. 19.
    Erasmus ME, Hofstede GJ, Petersen AH, et al (2002) Sp-a-enriched surfactant for treatment of rat lung transplants with sp-a deficiency after storage and reperfusion. Transplantation 73:348–352CrossRefPubMedGoogle Scholar
  20. 20.
    Hohlfeld JM, Tiryaki E, Hamm R, et al (1998) Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Care Med 158:706–712PubMedGoogle Scholar
  21. 21.
    Haitsma JJ, Papadakos PJ, Lachmann B (2004) Surfactant therapy for acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 10:18–22CrossRefPubMedGoogle Scholar
  22. 22.
    Griese M (1999) Pulmonary surfactant in health and human lung diseases: State of the art. Eur Respir J 13:1455–1476PubMedGoogle Scholar
  23. 23.
    Haitsma JJ, Lachmann RA, Lachmann B (2003) Lung protective ventilation in ards: Role of mediators, peep and surfactant. Monaldi Arch Chest Dis 59:108–118PubMedGoogle Scholar
  24. 24.
    Lachmann B, Eijking EP, So KL, Gomroers D (3994) In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function. Intensive Care Med 20:6–11Google Scholar
  25. 25.
    Grace PA, Mathie RT (1999) Ischaemia-reperfusion Injury. Blackwell Science Ltd, LondonGoogle Scholar
  26. 26.
    Buchanan SA, Mauney MC, Parekh VI, et al (1996) Intratracheal surfactant administration preserves airway compliance during lung reperfusion. Ann Thorac Surg 62:1617–1621CrossRefPubMedGoogle Scholar
  27. 27.
    Erasmus ME, Hofstede GJ, Petersen AH, Haagsman HP, Oetomo SB, Prop J (1997) Effects of early surfactant treatment persisting for one week after lung transplantation in rats. Am J Respir Crit Care Med 156:567–572PubMedGoogle Scholar
  28. 28.
    Gunther A, Balser M, Schmidt R, et al (2004) Surfactant abnormalities after single lung transplantation in dogs: Impact of bronchoscopic surfactant administration. J Thorac Cardiovasc Surg 127:344–354CrossRefPubMedGoogle Scholar
  29. 29.
    Struber M, Hohlfeld JM, Kofidis T, et al (2002) Surfactant function in lung transplantation after 24 hours of ischemia: Advantage of retrograde flush perfusion for preservation. J Thorac Cardiovasc Surg 123:98–103CrossRefPubMedGoogle Scholar
  30. 30.
    Koletsis E, Chatzimichalis A, Fotopoulos V, et al (2003) Donor lung pretreatment with surfactant in experimental transplantation preserves graft hemodynamics and alveolar morphology. Exp Biol Med (Maywood) 228:540–545Google Scholar
  31. 31.
    Krishnadasan B, Naidu B, Rosengart M, et al (2002) Decreased lung ischemia-reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus. J Thorac Cardiovasc Surg 123:756–767CrossRefPubMedGoogle Scholar
  32. 32.
    Takeyoshi I, Otani Y, Koibuchi Y, et al (1999) Effects of fr167653 on pulmonary ischemia-reperfusion injury: Administration timing. Transplant Proc 31:1935–1936CrossRefPubMedGoogle Scholar
  33. 33.
    Warnecke G, Sommer SP, Gohrbandt B, et al (2004) Warm or cold ischemia in animal models of lung ischemia-reperfusion injury: Is there a difference? Thorac Cardiovasc Surg 52:174–179CrossRefPubMedGoogle Scholar
  34. 34.
    Oosting RS, van Greevenbroek MM, Verhoef J, van Golde LM, Haagsman HP (1991) Structural and functional changes of surfactant protein a induced by ozone. Am J Physiol 261:L77–83PubMedGoogle Scholar
  35. 35.
    Friedrich I, Borgermann J, Splittgerber FH, et al (2004) Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation in dogs. J Thorac Cardiovasc Surg 127:335–343CrossRefPubMedGoogle Scholar
  36. 36.
    Warnecke G, Struber M, Fraud S, Hohlfeld JM, Haverich A (2001) Combined exogenous surfactant and inhaled nitric oxide therapy for lung ischemia-reperfusion injury in minipigs. Transplantation 71:1238–1244CrossRefPubMedGoogle Scholar
  37. 37.
    Andrade RS, Wangensteen OD, Jo JK, Tsai MY, Bolman RM 3rd (2000) Effect of hypothermic pulmonary artery flushing on capillary filtration coefficient. Transplantation 70:267–271CrossRefPubMedGoogle Scholar
  38. 38.
    Struber M, McGregor CG, Locke TJ, Miller VM (1990) Effect of flush-perfusion with eurocollins solution on pulmonary arterial function. Transplant Proc 22:2206–2211PubMedGoogle Scholar
  39. 39.
    Struber M, Ehlers KA, Nilsson FN, Miller VM, McGregor CG, Haverich A (1997) Effects of lung preservation with euro-collins and university of wisconsin solutions on endothelium-dependent relaxations. Ann Thorac Surg 63:1428–1435CrossRefPubMedGoogle Scholar
  40. 40.
    Struber M, Hoblfeld JM, Fraund S, Kim P, Warnecke G, Haverich A (2000) Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function. J Thorac Cardiovasc Surg 120:566–572CrossRefPubMedGoogle Scholar
  41. 41.
    Cockshutt AM, Weitz J, Possmayer F (1990) Pulmonary surfactant-associated protein a enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 29:8424–8429CrossRefPubMedGoogle Scholar
  42. 42.
    Semik M, Schnabel R, Bruske T, et al (1994) Ultrastructural studies of acute rejection following single lung transplantation in the rat-histological and immunohistological findings. Thorac Cardiovasc Surg 42:290–297PubMedGoogle Scholar
  43. 43.
    Hohlfeld JM, Struber M, Ahlf K, et al (1999) Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs. Eur Respir J 13:1037–1043CrossRefPubMedGoogle Scholar
  44. 44.
    Struber M, Wilhelmi M, Harringer W, et al (2001) Flush perfusion with low potassium, dextran solution improves early graft function in clinical lung transplantation. Eur J Cardiothorac Surg 19:190–194CrossRefPubMedGoogle Scholar
  45. 45.
    Novick RJ, MacDonald J, Veldhuizen RA, et al (1996) Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation. Am J Respir Crit Care Med 154:98–104PubMedGoogle Scholar
  46. 46.
    Hausen B, Rohde R, Hewitt CW, et al (1997) Exogenous surfactant treatment before and after sixteen hours of ischemia in experimental lung transplantation. J Thorac Cardiovasc Surg 113:1050–1058PubMedGoogle Scholar
  47. 47.
    Casals C, Varela A, Ruano ML, et al (1998) Increase of c-reactive protein and decrease of surfactant protein a in surfactant after lung transplantation. Am J Respir Crit Care Med 157:43–49PubMedGoogle Scholar
  48. 48.
    Novick RJ, Gehman KE, Ali IS, Lee J (1996) Lung preservation: The importance of endothelial and alveolar type ii cell integrity. Ann Thorac Surg 62:302–314CrossRefPubMedGoogle Scholar
  49. 49.
    Thomassen MJ, Meeker DP, Antal JM, Connors MJ, Wiedemann HP (1992) Synthetic surfactant (exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am J Respir Cell Mol Biol 7:257–260PubMedGoogle Scholar
  50. 50.
    Speer CP, Gotze B, Curstedt T, Robertson B (1991) Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (curosurf). Pediatr Res 30:69–74PubMedGoogle Scholar
  51. 51.
    Matalon S, Holm BA, Baker RR, Whitfield MK, Freeman BA (1990) Characterization of antioxidant activities of pulmonary surfactant mixtures. Biochim Biophys Acta 1035:121–127PubMedGoogle Scholar
  52. 52.
    Struber M, Hirt SW, Cremer J, Harringer W, Haverich A (1999) Surfactant replacement in reperfusion injury after clinical lung transplantation. Intensive Care Med 25:862–864CrossRefPubMedGoogle Scholar
  53. 53.
    Struber M, Cremer J, Harringer W, Hirt SW, Costard-Jackle A, Haverich A (1995) Nebulized synthetic surfactant in reperfusion injury after single lung transplantation. J Thorac Cardiovasc Surg 110:563–564PubMedGoogle Scholar
  54. 54.
    Della Rocca G, Pierconti F, Costa MG, et al (2002) Severe reperfusion lung injury after double lung transplantation. Crit Care 6:240–244PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • N.P. Van der Kaaij
  • A.J.J.C. Bogers
  • B. Lachmann

There are no affiliations available

Personalised recommendations